About: Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Creator	Blasi, Francesco Prat, Cristina Aliberti, Stefano Carugati, Manuela Irfan, Muhammad Faverio, Paola Gori, Andrea Restrepo, Marcos Reyes, Luis Soni, Nilam Sadud, Ricardo
source	Medline; PMC
abstract	This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired pneumonia (CAP) and to assess concordance with the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) and 2011 European Respiratory Society (ERS) CAP guidelines. This was a cohort study based on the Global Initiative for Methicillin-resistant Staphylococcus aureus Pneumonia (GLIMP) database, which contains point-prevalence data on adults hospitalised with CAP across 54 countries during 2015. In total, 3702 patients were included. Testing was performed in 3217 patients, and included blood culture (71.1%), sputum culture (61.8%), Legionella urinary antigen test (30.1%), pneumococcal urinary antigen test (30.0%), viral testing (14.9%), acute-phase serology (8.8%), bronchoalveolar lavage culture (8.4%) and pleural fluid culture (3.2%). A pathogen was detected in 1173 (36.5%) patients. Testing attitudes varied significantly according to geography and disease severity. Testing was concordant with IDSA/ATS and ERS guidelines in 16.7% and 23.9% of patients, respectively. IDSA/ATS concordance was higher in Europe than in North America (21.5% versus 9.8%; p<0.01), while ERS concordance was higher in North America than in Europe (33.5% versus 19.5%; p<0.01). Testing practices of adults hospitalised with CAP varied significantly by geography and disease severity. There was a wide discordance between real-life testing practices and IDSA/ATS/ERS guideline recommendations.
has issue date	2018-10-08(xsd:dateTime)
bibo:doi	10.1183/23120541.00096-2018
bibo:pmid	30474036
has license	cc-by-nc
sha1sum (hex)	43fb44b6c809c497fa4e6e7a52e7a3dbbebe4155
schema:url	https://doi.org/10.1183/23120541.00096-2018
resource representing a document's title	Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
has PubMed Central identifier	PMC6174282
has PubMed identifier	30474036
schema:publication	ERJ Open Res
resource representing a document's body	covid:43fb44b6c809c497fa4e6e7a52e7a3dbbebe4155#body_text
is schema:about of	named entity 'TESTING' named entity 'ADULTS' named entity 'STUDY' named entity 'TEXAS' named entity 'REAL' named entity 'SAN ANTONIO' named entity 'CONCORDANCE' named entity 'SOUTH' named entity 'HEALTH' named entity 'UNIVERSITY' named entity 'VETERANS HEALTH' named entity 'LIFE' named entity 'ASSESS' named entity 'HEALTH CARE SYSTEM' named entity 'COMMUNITY-ACQUIRED PNEUMONIA' named entity 'TO DESCRIBE' named entity 'CAP' named entity 'South Texas' named entity 'Methicillin-resistant Staphylococcus aureus' named entity 'antimicrobials' named entity 'ERS' named entity 'pathogen' named entity 'epidemiological data' named entity 'ERS' named entity 'CAP' named entity 'ERS' named entity 'sputum production' named entity 'p<0.01' named entity 'laboratory testing' named entity 'ERS' named entity 'pathogen' named entity 'leukocytosis' named entity 'IBM' named entity 'intensive care unit' named entity 'broth microdilution' named entity 'Mortality rates' named entity 'CAP' named entity 'p<0.01' named entity 'thoracic' named entity 'Infectious Diseases Society of America' named entity 'IDSA' named entity 'influenza' named entity 'diagnostic testing' named entity 'diagnostic test' named entity 'diagnostic testing' named entity 'IDSA' named entity 'purulent' named entity 'ultrasound' named entity 'Chlamydophila pneumoniae' named entity 'viral testing' named entity 'ATS' named entity 'diagnostic tests' named entity 'analytical techniques' named entity 'pathogen' named entity 'antimicrobial' named entity 'ERS' named entity 'GLIMP' named entity 'IDSA' named entity 'procalcitonin' named entity 'p<0.01' named entity 'ATS' named entity 'sputum' named entity 'p-value' named entity 'antibiotic therapy' named entity 'CAP' named entity 'antigen test' named entity 'laboratory technique' named entity 'Legionella' named entity 'tracheostomy' named entity 'study population' named entity 'ERS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software